Skip to content
ITIF Logo
ITIF Search

Science and R&D

As nations engage in a race for global advantage in innovation, ITIF champions a new policy paradigm that ensures businesses and national economies can compete successfully by spurring public and private investment in foundational areas such as research, skills, and 21st century infrastructure. In the area of science and R&D policy, ITIF promotes public and private investment in research and development through public funding for research at national laboratories and universities, tax incentives to encourage business R&D, and policies to spur technology transfer from lab to market.

Robert D. Atkinson
Robert D. Atkinson

President

Information Technology and Innovation Foundation

Read Bio
Stephen Ezell
Stephen Ezell

Vice President, Global Innovation Policy, and Director, Center for Life Sciences Innovation

Information Technology and Innovation Foundation

Read Bio
L. Val Giddings
L. Val Giddings

Senior Fellow

Information Technology and Innovation Foundation

Read Bio
Sejin Kim
Sejin Kim

Associate Director, Center for Korean Innovation and Competitiveness

Information Technology and Innovation Foundation

Read Bio
Trelysa Long
Trelysa Long

Policy Analyst

Schumpeter Project on Competition Policy

Read Bio
Lawrence Zhang
Lawrence Zhang

Head of Policy, Centre for Canadian Innovation and Competitiveness

Information Technology and Innovation Foundation

Read Bio

Featured

China Is Rapidly Becoming a Leading Innovator in Advanced Industries

China Is Rapidly Becoming a Leading Innovator in Advanced Industries

There may be no more important question for the West’s competitive position in advanced industries than whether China is becoming a rival innovator. While the evidence suggests it hasn’t yet taken the overall lead, it has pulled ahead in certain areas, and in many others Chinese firms will likely equal or surpass Western firms within a decade or so.

Why Congress Should Restore Full Expensing for Investments in Equipment and Research and Development

Why Congress Should Restore Full Expensing for Investments in Equipment and Research and Development

The tax law allowing firms to fully expense their research and development (R&D) costs expired at the end of 2021, and full expensing of equipment costs will begin phasing out in 2023. This decreases firms’ incentive to invest in these key drivers of economic growth and competitiveness. Congress should restore and make permanent full expensing for these investments.

More Publications and Events

December 18, 2025|Blogs

US Brain Drain Threatens Scientific and Biopharmaceutical Leadership

The United States risks a serious brain drain as NIH funding cuts, canceled grants, and program rollbacks push early-career scientists abroad, threatening America’s long-term biomedical capacity, innovation leadership, and national competitiveness unless policymakers act to stabilize and strengthen research support.

December 18, 2025|Testimonies & Filings

Comments to OSTP Regarding Accelerating the American Scientific Enterprise

The science community must move beyond the linear model of scientific research developed and encouraged by Vannevar Bush, and realign scientific exploration with national interests, especially in the face of the growing technological and economic threat posed by China.

December 8, 2025|Blogs

Fact of the Week: Public R&D Investment in Brazil Increased National Agricultural Productivity by 110 Percent

From 1970 to the present, agricultural research conducted by a public research foundation in Brazil has increased Brazilian agricultural productivity by 110 percent.

December 4, 2025|Blogs

Innovation Doesn’t Equal Productivity, and Patents Don’t Always Represent Innovation

Economists’ reliance on R&D and patent metrics distorts our understanding of productivity growth. Time to correct the conclusion: Here’s why these proxies fail to capture the forces that do drive it.

November 21, 2025|Blogs

Patterns of US-based Firms’ Foreign R&D Investments

Research and development (R&D) is central to a firm’s competitiveness, both domestically and internationally. Data from the National Science Foundation shows that U.S.-based firms have increased foreign R&D investment flows over the last decade.

November 17, 2025|Blogs

The Case for Expanding Federal and State R&D Incentives

U.S. R&D is becoming increasingly concentrated in a handful of states just as China accelerates its lead in advanced industries. Federal and state policymakers must expand R&D tax incentives and targeted academic research funding to reverse this trend, spur nationwide innovation, and bolster U.S. competitiveness.

November 14, 2025|Blogs

USG Investment in Industrial Research Low Compared to OECD Peers

The United States is investing less in R&D for industrial production than its OECD peers. Congress should increase investment in this area to better compete with China.

November 3, 2025|Blogs

Fact of the Week: University Patents Underpinned 50 Percent of FDA-approved Drugs

Since the Bayh-Dole Act was passed 50 percent of FDA-approved drugs today rely on (at least some) applied research originating in universities.

November 3, 2025|Blogs

Fact of the Week: R&D Investment Is Slowing in OECD Countries, From 3.6 Percent to 2.4 Percent

Between 2022 and 2023, R&D investment in Organization for Economic Cooperation and Development (OECD) nations grew by 2.4 percent, a slowdown from the 3.6 percent growth the previous year.

October 29, 2025|Blogs

Government Funding: The Unsung Hero of Innovation and Progress

The government-funded research initiatives that sustain our intellectual infrastructure—the body of scientific knowledge that underpins success in all other domains—must continue and receive more support than they have previously.

Back to Top